Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
The Comparative Advantage of Educated Workers in Implementing New Technology
1987612 citationsAnn P. Bartel, Frank R. Lichtenbergprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Frank R. Lichtenberg
Since
Specialization
Citations
This map shows the geographic impact of Frank R. Lichtenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank R. Lichtenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank R. Lichtenberg more than expected).
Fields of papers citing papers by Frank R. Lichtenberg
This network shows the impact of papers produced by Frank R. Lichtenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank R. Lichtenberg. The network helps show where Frank R. Lichtenberg may publish in the future.
Co-authorship network of co-authors of Frank R. Lichtenberg
This figure shows the co-authorship network connecting the top 25 collaborators of Frank R. Lichtenberg.
A scholar is included among the top collaborators of Frank R. Lichtenberg based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Frank R. Lichtenberg. Frank R. Lichtenberg is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lichtenberg, Frank R.. (2016). The Impact of Biomedical Research on U.S. Cancer Mortality: A Bibliometric Analysis. NBER Chapters. 475–504.2 indexed citations
8.
Lichtenberg, Frank R.. (2012). Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-Income Countries, 2000-2009. SSRN Electronic Journal.1 indexed citations
9.
Lleras‐Muney, Adriana & Frank R. Lichtenberg. (2010). Are the More Educated More LIkely to Use New Drugs. Annals of Economics and Statistics. 671–696.3 indexed citations
10.
Lichtenberg, Frank R.. (2010). Has Medical Innovation Reduced Cancer Mortality. SSRN Electronic Journal.1 indexed citations
11.
Lichtenberg, Frank R., Bengt Jönsson, & Nils Wilking. (2007). Pharmaceutical Innovation and Cancer Survival. SSRN Electronic Journal.
12.
Lichtenberg, Frank R.. (2006). Has Using Newer Drugs Reduced Admissions to Hospitals and Nursing Homes. Zeitschrift für schweizerische Statistik und Volkswirtschaft/Schweizerische Zeitschrift für Volkswirtschaft und Statistik/Swiss journal of economics and statistics. 142. 69–75.1 indexed citations
Lichtenberg, Frank R.. (2002). New Drugs: Health and Economic Impacts. (Research Summaries). 5.2 indexed citations
15.
Lichtenberg, Frank R., et al.. (2002). Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as. SSRN Electronic Journal.8 indexed citations
Lichtenberg, Frank R.. (1988). The Private R&D Investment Response to Federal Design and Technical Competitions. American Economic Review. 78(3). 550–559.144 indexed citations
19.
Lichtenberg, Frank R.. (1988). Government Subsidies to Private Military R&D Investment: DOD's IR&D Policy. National Bureau of Economic Research.1 indexed citations
20.
Lichtenberg, Frank R.. (1984). The Relationship between Federal Contract R&D and Company R&D. American Economic Review. 74(2). 73–78.112 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.